Global Assisted Reproductive Technology (ART) Market, By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking), Technology (In-vitro Fertilization (IVF), Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Surrogacy, Ovulation Induction, Others), Product Type (Women Younger Than Age 35, Women Older Than Age 35), End Use (Hospitals, Fertility Clinics, Others) – Industry Trends and Forecast to 2030.
Assisted Reproductive Technology (ART) Market Analysis and Size
Rising infertility rates, improved ART success rates, and increasing disposable income in developing countries are expected to drive industry growth during the forecast period. According to the World Health Organization Statistics 2020, approximately 186 million people worldwide face infertility issues.
Data Bridge Market Research analyses that the assisted reproductive technology (ART) market which was USD 26.28 billion in 2022, is expected to reach USD 50.10 billion by 2030, at a CAGR of 8.4% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Assisted Reproductive Technology (ART) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking), Technology (In-vitro Fertilization (IVF), Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Surrogacy, Ovulation Induction, Others), Product Type (Women Younger Than Age 35, Women Older Than Age 35), End Use (Hospitals, Fertility Clinics, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
California Cryobank (U.S.), Bloom Fertility Centre (India), Anecova (Switzerland), CooperSurgical (U.S.), Merck KGaA (Germany), Ferring B.V. (Switzerland), FUJIFILM Irvine Scientific (U.S.), Genea Limited (Australia), Nidacon International AB (Sweden), Celmatix Inc. (U.S.), Esco Micro Pte Ltd. (Singapore), INVO Bioscience (U.S.), Laboratoire CCD (France), Nikon Instruments Inc. (U.S.), ICU Medical, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
ART procedures include ICSI (intracytoplasmic sperm injection), IVF (in vitro fertilization), cryopreservation of embryos or gametes, fertility medication use and others. The use of medical techniques to treat infertility is referred to as assisted reproductive technology (ART). According to the World Health Organization, infertility is defined as the inability to conceive after more than a year without using contraception. Infertility can affect both men and women. When the procedures are used to treat infertility, they are referred to as fertility treatment. ART is primarily used to treat infertility and reproductive endocrinology. Surrogacy orders are also influenced by ART.
Global Assisted Reproductive Technology (ART) Market Dynamics
Drivers
- Increased awareness of same-sex marriages
The growing number of single parents, as well as increased awareness of same-sex marriages and assisted reproductive technologies, are playing a significant role in the growth of the ART market during the forecast period. According to the Human Rights Campaign (HRC) Foundation's 2022 update, the same-sex marriage is legal in various countries and the number has increased to 32 in 2022, and parliamentary or court actions are underway in several countries, with this number expected to rise further. As a result of the increase in same-sex marriages, demand for ART techniques is expected to rise significantly, boosting growth in the market.
- Rising In-vitro fertilization
The IVF procedures is expected to have a significant share of the studied market because of the high procedural success rate and continuous advancement. According to a July 2021 article titled "Growth Trajectory of Fertility Segment in India," between 2 and 2.5 lac IVF procedures are performed in India each year, and the fertility industry in India has shown a 20% compound annual growth rate over the past five years. As a result, the in-vitro fertilization is expected to grow significantly during the forecast period.
Opportunities
- Technological advancements
Depending on the patient's needs, various techniques such as in vitro fertilization (IVF), artificial insemination, zygote intra-fallopian transfer (ZIFT), and gamete intra-fallopian transfer (GIFT) are used. In vitro fertilization is considered the gold standard for ART, because of the high success rate for embryo transfer and the increase in live birth rates. To prepare the body for ART treatment, drugs such as orals and injectable hormones are used both before and during the treatment. With an elaborate pipeline, the pharmaceutical market is expected to grow significantly. Furthermore, INVOcell and Anecova have developed In vivo ART devices that are expected to aid market growth during the forecast period.
Restraints/Challenges
- High cost of medical procedure
Increasing medical procedure costs and ethical concerns, as well as the risk of prematurity associated with assisted reproductive technologies and a lower success rate, will impede the growth of the assisted reproductive technologies (ART) market during the forecast period.
This assisted reproductive technology (ART) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the assisted reproductive technology (ART) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Assisted Reproductive Technology (ART) Market
The pandemic had a negative impact on the industry because of the shutdown of operations and subsequent decrease in patient care volumes. Post-pandemic, technological advancement and telehealth adoption in the field of ART are expected to boost industry growth. Telehealth adoption in ART services is still in its early stages. Nonetheless, it has enormous future potential due to remote monitoring and continuous management benefits.
Recent Developments
- In 2022, Inception Fertility expanded its ecosystem by launching HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that provides fertility providers and patients with a one-of-a-kind experience. It includes technology for assisted reproduction.
- In 2022, Birla Fertility, CK Birla Healthcare's flagship fertility clinic, will open with Assisted Reproductive Technology in New Delhi.
- In 2021, Virtus Health Limited, an Australian company that provides assisted reproductive technology, paid $45.0 million to Healius Limited for Adora Fertility and three-day hospitals. This acquisition will help Virtus Health strengthen its portfolio for in-vitro fertilization (IVF). Adora Fertility is an Australia-based company that provides assisted reproductive technology (ART) including IVF (In-vitro fertilization) and ICSI (Intracytoplasmic Sperm Injection).
Global Assisted Reproductive Technology (ART) Market Scope
The assisted reproductive technology (ART) market is segmented on the basis of procedure, technology, product type and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Procedure
- Fresh Donor
- Fresh Nondonor
- Frozen Donor
- Frozen Nondonor
- Embryo/Egg Banking
Technology
- In-vitro Fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without ICSI
- Artificial Insemination - Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Surrogacy
- Ovulation Induction
- Others
Product Type
- Women Younger Than Age 35
- Women Older Than Age 35
End Use
- Hospitals
- Fertility Clinics
- Others
Assisted Reproductive Technology (ART) Market Regional Analysis/Insights
The assisted reproductive technology (ART) market is analysed and market size insights and trends are provided by country, procedure, technology, product type and end-use as referenced above.
The countries covered in the assisted reproductive technology (ART) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the assisted reproductive technology (ART) market due to rising infertility rates and increasing fertility treatment awareness.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the adoption of late family planning and lower treatment cost.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The assisted reproductive technology (ART) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for assisted reproductive technology (ART) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the assisted reproductive technology (ART) market. The data is available for historic period 2011-2021.
Competitive Landscape and Assisted Reproductive Technology (ART) Market Share Analysis
The assisted reproductive technology (ART) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to assisted reproductive technology (ART) market.
Some of the major players operating in the assisted reproductive technology (ART) market are:
- California Cryobank (U.S.)
- Bloom Fertility Centre (India)
- Anecova (Switzerland)
- CooperSurgical (U.S.)
- Merck KGaA (Germany)
- Ferring B.V. (Switzerland)
- FUJIFILM Irvine Scientific (U.S.)
- Genea Limited (Australia)
- Nidacon International AB (Sweden)
- Celmatix Inc. (U.S.)
- Esco Micro Pte Ltd. (Singapore)
- INVO Bioscience (U.S.)
- Laboratoire CCD (France)
- Nikon Instruments Inc. (U.S.)
- ICU Medical, Inc. (U.S.)
SKU-